2019 Complicated Intra-Abdominal Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 64 pages | ID: 277A575D686EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Complicated Intra-Abdominal Infections Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Complicated Intra-Abdominal Infections. It presents in-depth analysis of Complicated Intra-Abdominal Infections clinical trials across markets and companies. The research work is for providing complete understanding into trends in Complicated Intra-Abdominal Infections.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Complicated Intra-Abdominal Infections clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Complicated Intra-Abdominal Infections

The research work is prepared through extensive and continuous research on Complicated Intra-Abdominal Infections trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Complicated Intra-Abdominal Infections patients are identified
• The report includes panorama of Complicated Intra-Abdominal Infections clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Complicated Intra-Abdominal Infections clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Complicated Intra-Abdominal Infections Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Complicated Intra-Abdominal Infections Clinical Trials by Region
  2.2.2 Average Enrollment of Complicated Intra-Abdominal Infections Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Complicated Intra-Abdominal Infections Treatment, 2019

3. REGION WISE COMPLICATED INTRA-ABDOMINAL INFECTIONS CLINICAL TRIALS

3.1 Asia Pacific Complicated Intra-Abdominal Infections Clinical Trials by Country
3.2 Europe Complicated Intra-Abdominal Infections Clinical Trials by Country
3.3 North America Complicated Intra-Abdominal Infections Clinical Trials by Country
3.4 Middle East and Africa Complicated Intra-Abdominal Infections Clinical Trials by Country
3.5 South and Central America Complicated Intra-Abdominal Infections Clinical Trials by Country

4. COMPLICATED INTRA-ABDOMINAL INFECTIONS CLINICAL TRIAL TRENDS

4.1 Start Year wise Complicated Intra-Abdominal Infections Clinical Trials
4.2 Phase wise Complicated Intra-Abdominal Infections Clinical Trials
4.3 Trial Status wise Complicated Intra-Abdominal Infections Clinical Trials
4.4 Trial Type wise Complicated Intra-Abdominal Infections Clinical Trials

5. COMPLICATED INTRA-ABDOMINAL INFECTIONS AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Complicated Intra-Abdominal Infections Trials by Year
5.2 Average Enrollment in Complicated Intra-Abdominal Infections Trials by Phase
5.3 Average Enrollment in Complicated Intra-Abdominal Infections Trials by Status
5.4 Average Enrollment in Complicated Intra-Abdominal Infections Trials by Type of Trial

6. COMPANIES PARTICIPATING IN COMPLICATED INTRA-ABDOMINAL INFECTIONS CLINICAL TRIALS

6.1 Complicated Intra-Abdominal Infections Trials by Sponsor Type
6.2 Complicated Intra-Abdominal Infections Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Complicated Intra-Abdominal Infections Trials- Phase
7.2 Complicated Intra-Abdominal Infections Trials- Phase
7.3 Complicated Intra-Abdominal Infections Trials- Phase
7.4 Complicated Intra-Abdominal Infections Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Complicated Intra-Abdominal Infections Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Complicated Intra-Abdominal Infections Clinical Trials and Enrolment
Figure 5: Europe – Country wise Complicated Intra-Abdominal Infections Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Complicated Intra-Abdominal Infections Clinical Trials and Enrolment
Figure 7: North America – Country wise Complicated Intra-Abdominal Infections Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Complicated Intra-Abdominal Infections Clinical Trials and Enrolment
Figure 9: Complicated Intra-Abdominal Infections Clinical Trials by Phase
Figure 10: Complicated Intra-Abdominal Infections Clinical Trials by Trial Status
Figure 11: Complicated Intra-Abdominal Infections Clinical Trials by Type
Figure 12: Complicated Intra-Abdominal Infections Clinical Trials by Sponsor Type
Figure 13: Complicated Intra-Abdominal Infections Clinical Trials by Leading Sponsors
Figure 14: Complicated Intra-Abdominal Infections Average Enrollment by Phase
Figure 15: Complicated Intra-Abdominal Infections Average Enrollment by Trial Status
Figure 16: Complicated Intra-Abdominal Infections Average Enrollment by Type
Figure 17: Complicated Intra-Abdominal Infections- Average Enrolment by Type of Sponsors
Figure 18: Complicated Intra-Abdominal Infections- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Complicated Intra-Abdominal Infections Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Complicated Intra-Abdominal Infections Clinical Trials and Enrolment
Table 5: Europe – Country wise Complicated Intra-Abdominal Infections Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Complicated Intra-Abdominal Infections Clinical Trials and Enrolment
Table 7: North America – Country wise Complicated Intra-Abdominal Infections Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Complicated Intra-Abdominal Infections Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Complicated Intra-Abdominal Infections Average Enrollment by Phase
Table 15: Complicated Intra-Abdominal Infections Average Enrollment by Trial Status
Table 16: Complicated Intra-Abdominal Infections Average Enrollment by Type
Table 17: Complicated Intra-Abdominal Infections- Average Enrolment by Type of Sponsors
Table 18: Complicated Intra-Abdominal Infections- Enrolment by Leading Sponsors